Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 30%
Hold 30%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is a dominant player in the hospital industry, operating a large network of acute care hospitals, outpatient facilities, and other settings. Amidst struggling fundamentals for the industry, HCA has continued to outperform due to its strong management team and impressive growth trends, aided by market share gains in faster-growing markets. While the company faces significant challenges such as bad debt expense and potential investigations, its solid financial performance and leading position in the healthcare market make it a strong investment opportunity with an Outperform rating. The company is also actively implementing sustainability initiatives to reduce its environmental impact.

Bears say

HCA Healthcare is facing significant challenges in the current healthcare landscape, with a low visibility and understanding of its management's strategy and the impact of exchanges on its business. The company's reliance on government programs and Medicaid conversion trends, along with cost pressures and competition in its markets, present significant risks for its financial performance in the future. These factors, coupled with a potential slowdown in admissions growth and potential cost headwinds, have led to a negative outlook on the stock.

HCA Healthcare (HCA) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 20 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $499.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $499.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.